pharmaceuticals

Preparedness for the challenges of viral infection and application of knowledge of biosafety technologies by students

The state of development of the disease on COVID-19 is analyzed, the need to comply with the principles of biosafety, competency base, which provide training for biotechnology and pharmaceuticals to create new effective drugs, including antiviral drugs, is emphasized. Introduction and deepening of knowledge of the principles of biosafety and biosecurity, the use of molecular PCR tests, serological ELISA tests, knowledge of the dangers of dual use of experimental studies affects almost all disciplines of "Biotechnology and Bioengineering" and "Pharmacy, Industrial Pharmacy".